These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy. Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679 [TBL] [Abstract][Full Text] [Related]
23. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis. Cao Y; Ding Z; Han C; Shi H; Cui L; Lin R Dig Dis Sci; 2017 Apr; 62(4):851-860. PubMed ID: 28168575 [TBL] [Abstract][Full Text] [Related]
32. GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy. Aghayan HR; Goodarzi P; Arjmand B Methods Mol Biol; 2015; 1283():93-107. PubMed ID: 25138723 [TBL] [Abstract][Full Text] [Related]
33. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report. Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936 [TBL] [Abstract][Full Text] [Related]
34. An Innovative, Comprehensive Mapping and Multiscale Analysis of Registered Trials for Stem Cell-Based Regenerative Medicine. Monsarrat P; Vergnes JN; Planat-Bénard V; Ravaud P; Kémoun P; Sensebé L; Casteilla L Stem Cells Transl Med; 2016 Jun; 5(6):826-35. PubMed ID: 27075765 [TBL] [Abstract][Full Text] [Related]
35. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy? Ezquer F; Ezquer M; Arango-Rodriguez M; Conget P Acta Ophthalmol; 2014 Mar; 92(2):e86-95. PubMed ID: 23773776 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic application of mesenchymal stromal cells in murine models of inflammatory bowel disease. Gonzalez-Rey E; Delgado M Methods Mol Biol; 2014; 1213():331-9. PubMed ID: 25173395 [TBL] [Abstract][Full Text] [Related]
37. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Forostyak S; Jendelova P; Sykova E Biochimie; 2013 Dec; 95(12):2257-70. PubMed ID: 23994163 [TBL] [Abstract][Full Text] [Related]
39. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review. Vonk LA; de Windt TS; Slaper-Cortenbach IC; Saris DB Stem Cell Res Ther; 2015 May; 6(1):94. PubMed ID: 25976213 [TBL] [Abstract][Full Text] [Related]
40. Potential therapeutic applications of mesenchymal stromal cells. Larsen S; Lewis ID Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]